Maria Glymour
Profiles

Maria Glymour, SD

Chair and Professor, Epidemiology - Boston University School of Public Health

Biography

Research Interests
- Alzheimer's disease and related causes of cognitive aging and dementia
- Social determinants of health and health equity
- Social policies and health
- Causal inference in social epidemiology and dementia research

My research focuses on how social factors experienced across the lifecourse, from infancy to adulthood, influence cognitive function, dementia, stroke, and other health outcomes in old age. I am especially interested in education and other exposures amenable to policy interventions. The health of current cohorts of elderly individuals in the US reflect a lifetime of social exposures, including educational experiences shaped by major changes in schooling policies. Education is especially interesting because it is such a powerful predictor of health and historically, access to education has frequently been restricted based on race, gender, and other socially enforced criteria. One thread of my research examines how changes in schooling laws and school quality in the 20th century might have influenced the health and cognitive outcomes of current cohorts of elderly, including adults subject to race-based school segregation. Our results suggest that extra schooling has substantial benefits for memory function in the elderly. I have also worked on the influence of "place" on health, for example to understand the excess stroke burden for individuals who grew up in the US Stroke Belt. In a project with colleagues including Drs. Rachel Whitmer, Elizabeth Rose Mayeda, and Paola Gilsanz, we are continuing a unique multi-ethnic cohort of older adults in Northern California, with a wealth of lifecourse biological and social data to offer insight into the reasons for racial/ethnic differences in Alzheimer's and dementia risk (https://rachelwhitmer.ucdavis.edu/khandle).

A separate theme of my research focuses on overcoming methodological problems encountered in analyses of social determinants of health, Alzheimer's disease, and dementia. For many reasons, research focusing on lifecourse epidemiology as well as cognitive aging introduces substantial methodological challenges. Sometimes, these are conceptual challenges, and clear causal thinking can help! Many of these challenges are being addressed in the MELODEM (MEthods in LOngitudinal research on DEMentia) initiative, an international group of researchers focusing on analytic challenges in research on dementia and cognitive aging. MELODEM has working group phone calls on the first and third Thursdays of the month, open to all (https://sites.bu.edu/melodem/). My group works with numerous colleagues on methods to improve measurement, including crosswalking across data sets. For example, in work with Dr. Zeki Al Hazzouri, we are linking data sets with detailed information at different lifecourse periods -- e.g., childhood, early adulthood, and later adulthood -- to better evaluate long-term effects of exposures at specific sensitive ages. In work with Dr. Cathy Schaefer, Ron Krauss, and many others, we are fielding emulated trial designs in the large, diverse Kaiser Permanente Northern California cohort. This setting is exceptional for emulated trial designs because of the large size, long follow-up, and combination of high-quality clinical data plus social and genetic information for large groups of study participants.

I have advocated the use of causal directed acyclic graphs (DAGs) as a standard research tool to represent our causal hypotheses and help elucidate potential biases in proposed analyses. In other cases, the methodological problems require more analytical solutions that have been developed elsewhere in epidemiology or in other disciplines, but are rarely applied to these research questions. Instrumental variables analyses of natural or induced experiments are one promising example. Genetic variations have recently been advanced as possible instrumental variables to estimate the health effects of a wide range of phenotypes, an approach sometimes called “Mendelian Randomization.” Using genetic polymorphisms as instrumental variables could provide a very powerful tool for social epidemiology, but the inferences from such analyses rest on strong assumptions. Thus I am currently working with a team to explore approaches to evaluating the plausibility of those assumptions in applications for social epidemiology.

Students and post-doctoral fellows interested in research collaborations related to my work are welcome to send me an email directly or contact Robin Hyatt, rshyatt@bu.edu, who handles my calendar.

Education

  • Harvard School of Public Health, SD Field of Study: Epidemiology
  • Harvard School of Public Health, SM/ScM Field of Study: Epidemiology
  • University of Chicago, AB Field of Study: Biology

Classes Taught

  • SPHEP912

Publications

  • Published on 5/29/2025

    Griswold ME, Glymour MM. Time and Age as Longitudinal Timescales: Multiple Useful Models are Illuminating. Epidemiology. 2025 Jul 01; 36(4):572-579. PMID: 40439240.

    Read At: PubMed
  • Published on 5/3/2025

    Ferguson EL, Zimmerman SC, Jiang C, Choi M, Meyers TJ, Hoffmann TJ, Gilsanz P, Wang J, Oni-Orisan A, Whitmer RA, Risch N, Krauss RM, Patel CJ, Schaefer CA, Glymour MM. Uncertainty in the estimated effects of statin initiation on risk of dementia: using a multiverse analysis to assess sources of variability. Eur J Epidemiol. 2025 Apr; 40(4):407-417. PMID: 40317408.

    Read At: PubMed
  • Published on 5/1/2025

    Murchland AR, Haneuse S, Lawn RB, Berkman L, Jakubowski K, Glymour MM, Koenen KC. Intimate partner violence and cognitive functioning - toward quantifying dementia risk. Alzheimers Dement. 2025 May; 21(5):e70029. PMID: 40318131.

    Read At: PubMed
  • Published on 4/29/2025

    Sims KD, Neilands TB, Johnson JK, Tabb LP, Safford MM, Lovasi GS, Judd SE, Bibbins-Domingo K, Glymour MM. Neighborhood characteristics and incident myocardial infarction in US older adults: evaluation in two nationwide cohorts. Am J Epidemiol. 2025 Apr 29. PMID: 40302120.

    Read At: PubMed
  • Published on 4/1/2025

    Choi M, Zimmerman SC, Buto PT, Wang J, Brenowitz WD, Hoffmann TJ, Hazzouri AZA, Kezios K, Glymour MM. Association of genetic risk score for Alzheimer's disease with late-life body mass index in all of us: Evaluating reverse causation. Alzheimers Dement. 2025 Apr; 21(4):e14598. PMID: 40189781.

    Read At: PubMed
  • Published on 4/1/2025

    Wang J, Choi M, Buto P, Kelly JD, La Joie R, Kornak J, Zimmerman SC, Chen R, Raphael E, Schaefer CA, Blacker D, Glymour MM. Detection Bias in EHR-Based Research on Clinical Exposures and Dementia. JAMA Netw Open. 2025 Apr 01; 8(4):e256637. PMID: 40266617.

    Read At: PubMed
  • Published on 3/30/2025

    Owens JH, Windon CC, Mungas D, Whitmer RA, Gilsanz P, Manly JJ, Glymour MM. Positive Childhood Experiences, Cognition, and Biomarkers of Alzheimer's Disease. Int J Environ Res Public Health. 2025 Mar 30; 22(4). PMID: 40283750.

    Read At: PubMed
  • Published on 3/27/2025

    Gutierrez S, Glymour MM, Smith GD. Evidence triangulation in health research. Eur J Epidemiol. 2025 Mar 27. PMID: 40140142.

    Read At: PubMed
  • Published on 3/19/2025

    Pacca L, Gaye SA, Brenowitz WD, Fujishiro K, Glymour MM, Harrati A, Vable AM. Do type, timing and duration of life course non-employment differentially predict dementia risk? An application of sequence analysis. Soc Sci Med. 2025 May; 372:117976. PMID: 40147331.

    Read At: PubMed
  • Published on 3/7/2025

    Thoma MC, Wang J, Mayeda ER, McCulloch CE, Hayes-Larson E, Torres JM, Glymour MM. Are we there yet? Estimating the waves of follow-up required for stable effect estimates in cognitive aging research. Am J Epidemiol. 2025 Mar 07. PMID: 40069951.

    Read At: PubMed

News & In the Media